Indo-MIM
- Issue price
- ₹ 485
- Issue size
- ₹ 3,811.21 Cr.
- Min. investment
- ₹ 14,550
- Listing price
- ₹ 700
- Subscribed
- 72.34x
- Lot size
- 30 shares
- P/E
- 44.95
- RoNW
- 21.26%
- RoCE
- 26.60%
- Debt / Equity
- 0.39
- PAT margin
- 12.72%
- EBITDA margin
- 25.54%
- RoE
- 21.26%
- EPS
- ₹ 10.79
- NAV
- ₹ 58.24
- Promoter stake
- 77.65%
About
Indo-MIM Limited, founded in 1996 and headquartered in Bengaluru, is the world's largest producer of Metal Injection Molding (MIM) components by installed capacity, holding roughly 6.8% of the global MIM market (2025). The company provides end-to-end precision engineering solutions spanning mold design, tooling, MIM, investment casting, precision machining, ceramic injection molding, metal 3D printing and assembly. It operates 15 manufacturing facilities across India, the United States, the United Kingdom and Mexico, serving more than 1,100 customers worldwide across the automotive, defence, medical, aerospace and consumer sectors. International markets accounted for about 77.2% of revenue in Fiscal 2026. The company holds NADCAP, IATF 16949 and AS9100 quality certifications supporting its presence in regulated industries.
Timeline
- doneOpens23 Jul
- doneCloses27 Jul
- doneAllotment28 Jul
- doneRefunds29 Jul
- doneDemat credit29 Jul
- doneListing30 Jul
Grey market premium (GMP)
GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
- Highest
- ₹ 199 on 19 Jul 2026
- Lowest
- ₹ 168 on 18 Jul 2026
- First quoted
- ₹ 168 on 18 Jul 2026
Subscription
How many times each investor group bid for its share, as of 08 Aug 2026, 04:05 PM IST.
How much to apply for
The smallest and largest bids for each kind of investor at the upper price band.
| Retail (Min) | 1 | 30 | ₹ 14,550 |
| Retail (Max) | 13 | 390 | ₹ 1,89,150 |
| S-HNI (Min) | 14 | 420 | ₹ 2,03,700 |
| B-HNI (Min) | 69 | 2,070 | ₹ 10,03,950 |
Company overview
Financials
| Revenue | 4,320.7 | 3,373.97 | 2,900.38 |
| OPM % | 24.79 | 27.64 | 25.63 |
| EBITDA | 1,070.92 | 932.59 | 743.46 |
| Net Profit | 533.54 | 423.73 | 283.73 |
| Debt | 1,090.49 | 1,247.2 | 1,085.01 |
| Assets | 4,897.33 | 4,140.84 | 3,757.51 |
Strengths
- World's largest installed Metal Injection Molding (MIM) capacity, with end-to-end capability from design to assembly
- Highly diversified customer base across automotive, defence, medical, aerospace and consumer sectors, reducing single-industry risk
- Strong revenue and profit growth, with PAT up 88% and total income up 49% between FY24 and FY26
- Global manufacturing footprint across India, the US, UK and Mexico supporting multinational customers
- Quality accreditations (NADCAP, IATF 16949, AS9100) enabling participation in regulated industries
Risks
- Operates on a purchase-order basis without binding long-term commitments from customers, creating revenue volatility risk
- Significant dependence on imported raw materials exposes the business to commodity price swings, currency fluctuations and geopolitical disruption
- Multi-plant operations across geographies face equipment, labour and operational disruption risks
- Elevated valuation at the upper price band, with a post-IPO P/E of about 44.95x and Price/Book of about 10.63x
- Large Offer-for-Sale component (Rs 3,312.11 Cr of the Rs 3,812.11 Cr issue), limiting fresh capital available for the company's own growth
What the money is for
| Repayment/prepayment of certain outstanding borrowings availed by the Company | 400 |
| General corporate purposes | — |
Promoters
- Dr. Krishna Chivukula
- Krishna Chivukula Jr
- Jagadamba Chandrasekhar
- Green Meadows Investments Ltd
Anchor investors
92 anchors put in ₹ 1,140.98 Cr., including 60 mutual funds.
| ICICI PRUDENTIAL MANUFACTURING FUND | 9,48,420 | 46 | 4.03% |
| ISIF HYBRID LONG-SHORT FUND | 1,75,260 | 8.5 | 0.74% |
| ICICI PRUDENTIAL BALANCED HYBRID FUND | 41,250 | 2 | 0.18% |
| ICICI PRUDENTIAL QUANT FUND | 41,250 | 2 | 0.18% |
| ISIF EQUITY LONG-SHORT FUND | 30,930 | 1.5 | 0.13% |
| HDFC DEFENCE FUND | 2,92,110 | 14.17 | 1.24% |
| HDFC MULTI CAP FUND | 2,74,890 | 13.33 | 1.17% |
| HDFC CHILDREN'S FUND | 2,74,890 | 13.33 | 1.17% |
| HDFC INNOVATION FUND | 1,20,300 | 5.83 | 0.51% |
| HDFC MANUFACTURING FUND | 1,20,300 | 5.83 | 0.51% |
| HDFC BUSINESS CYCLE FUND | 1,03,080 | 5 | 0.44% |
| HDFC MNC FUND | 51,540 | 2.5 | 0.22% |
| SBI MNC FUND | 4,12,380 | 20 | 1.75% |
| SBI INFRASTRUCTURE FUND | 3,91,740 | 19 | 1.67% |
| SBI QUALITY FUND | 3,91,740 | 19 | 1.67% |
| SBI CHILDREN'S FUND-SAVINGS PLAN | 41,250 | 2 | 0.18% |
| KOTAK CONTRA FUND | 2,06,190 | 10 | 0.88% |
| KOTAK BUSINESS CYCLE FUND | 2,06,190 | 10 | 0.88% |
| KOTAK SPECIAL OPPORTUNITIES FUND | 2,06,190 | 10 | 0.88% |
| KOTAK TRANSPORTATION & LOGISTICS FUND | 2,06,190 | 10 | 0.88% |
| KOTAK MNC FUND | 2,06,190 | 10 | 0.88% |
| KOTAK MANUFACTURE IN INDIA FUND | 2,06,160 | 10 | 0.88% |
| ADITYA BIRLA SUN LIFE FLEXI CAP FUND | 4,12,380 | 20 | 1.75% |
| ADITYA BIRLA SUN LIFE INFRASTRUCTURE FUND | 4,12,380 | 20 | 1.75% |
| ADITYA BIRLA SUN LIFE MIDCAP FUND | 3,71,130 | 18 | 1.58% |
| APEX HYBRID LONG-SHORT FUND | 41,220 | 2 | 0.18% |
| ASHOKA WHITEOAK ICAV-ASHOKA WHITEOAK EMERGING MARKETS EQUITY FUND | 10,30,920 | 50 | 4.38% |
| WHITEOAK CAPITAL INDIA OPPORTUNITIES FUND | 2,06,190 | 10 | 0.88% |
| 360 ONE FLEXICAP FUND | 7,21,650 | 35 | 3.07% |
| 360 ONE MULTI-STAGE DEFENCE & SPACE FUND | 4,12,350 | 20 | 1.75% |
| DYNASIF EQUITY EX-TOP 100 LONG-SHORT FUND | 1,03,110 | 5 | 0.44% |
| ARANDA INVESTMENTS PTE.LTD. | 7,21,620 | 35 | 3.07% |
| GOVERNMENT PENSION FUND GLOBAL | 7,21,620 | 35 | 3.07% |
| GOLDMAN SACHS FUNDS-GOLDMAN SACHS INDIA EQUITY PORTFOLIO | 7,21,620 | 35 | 3.07% |
| AMANSA HOLDINGS PVT.LTD. | 7,21,620 | 35 | 3.07% |
| AXIS ELSS TAX SAVER FUND | 2,36,100 | 11.45 | 1% |
| AXIS SMALL CAP FUND | 2,16,750 | 10.51 | 0.92% |
| AXIS FLEXI CAP FUND | 98,730 | 4.79 | 0.42% |
| AXIS MULTICAP FUND | 77,070 | 3.74 | 0.33% |
| AXIS INDIA MANUFACTURING FUND | 38,520 | 1.87 | 0.16% |
| AXIS BALANCED ADVANTAGE FUND | 28,890 | 1.4 | 0.12% |
| AXIS MULTI ASSET ALLOCATION FUND | 16,830 | 0.82 | 0.07% |
| AXIS INNOVATION FUND | 9,630 | 0.47 | 0.04% |
| BANDHAN SMALL CAP FUND | 5,17,140 | 25.08 | 2.2% |
| HSBC SMALL CAP FUND | 3,76,110 | 18.24 | 1.6% |
| HSBC MULTI CAP FUND | 1,41,030 | 6.84 | 0.6% |
| MIRAE ASSET FOCUSED FUND | 4,63,890 | 22.5 | 1.97% |
| MIRAE ASSET INFRASTRUCTURE FUND | 53,250 | 2.58 | 0.23% |
| UTI INFRASTRUCTURE FUND | 3,10,290 | 15.05 | 1.32% |
| UTI MULTI CAP FUND | 2,06,850 | 10.03 | 0.88% |
| MOTILAL OSWAL SMALL CAP FUND | 5,17,140 | 25.08 | 2.2% |
| QSIF ACTIVE ASSET ALLOCATOR LONG-SHORT FUND | 2,06,850 | 10.03 | 0.88% |
| QSIF EQUITY EX-TOP 100 LONG-SHORT FUND | 3,10,290 | 15.05 | 1.32% |
| TATA INFRASTRUCTURE FUND | 2,48,220 | 12.04 | 1.06% |
| TATA RESOURCES & ENERGY FUND | 2,27,550 | 11.04 | 0.97% |
| TITANIUM EQUITY LONG-SHORT FUND | 41,370 | 2.01 | 0.18% |
| INVESCO INDIA INFRASTRUCTURE FUND | 2,06,850 | 10.03 | 0.88% |
| INVESCO INDIA MANUFACTURING FUND | 2,06,850 | 10.03 | 0.88% |
| SUMMIT EQUITY LONG-SHORT FUND | 1,03,440 | 5.02 | 0.44% |
| BLACKROCK GLOBAL FUNDS-INDIA FUND | 5,17,140 | 25.08 | 2.2% |
| PINEBRIDGE GLOBAL FUNDS-PINEBRIDGE INDIA EQUITY FUND | 4,14,030 | 20.08 | 1.76% |
| DSP INDIA FUND | 4,12,350 | 20 | 1.75% |
| ICICI PRUDENTIAL LIFE INSURANCE CO.LTD. | 4,12,350 | 20 | 1.75% |
| SBI LIFE INSURANCE CO.LTD. | 4,12,350 | 20 | 1.75% |
| HDFC LIFE INSURANCE CO.LTD. | 4,13,250 | 20.04 | 1.76% |
| BAJAJ LIFE INSURANCE LTD. | 4,12,350 | 20 | 1.75% |
| NATIXIS INTERNATIONAL FUNDS (LUX) I-LOOMIS SAYLES GLOBAL EMERGING MARKETS EQUITY FUND | 3,09,270 | 15 | 1.31% |
| KEDAARA CAPITAL PUBLIC MARKETS IFSC FUND I | 2,68,020 | 13 | 1.14% |
| EAMC ICAV-ENAM INDIA OPPORTUNITIES FUND | 2,06,190 | 10 | 0.88% |
| CANARA ROBECO MID CAP FUND | 3,10,980 | 15.08 | 1.32% |
| EDELWEISS BUSINESS CYCLE FUND | 2,16,480 | 10.5 | 0.92% |
| EDELWEISS RECENTLY LISTED IPO FUND | 51,540 | 2.5 | 0.22% |
| UNION LARGE & MIDCAP FUND | 2,06,190 | 10 | 0.88% |
| KOTAK FUNDS-INDIA MIDCAP FUND | 2,06,190 | 10 | 0.88% |
| 3P INDIA EQUITY FUND II M | 2,06,190 | 10 | 0.88% |
| FRANKLIN BUILD INDIA FUND | 2,06,190 | 10 | 0.88% |
| MANULIFE GLOBAL FUND-INDIA EQUITY FUND | 2,06,190 | 10 | 0.88% |
| ICICI LOMBARD GENERAL INSURANCE CO.LTD. | 2,06,190 | 10 | 0.88% |
| UNIFI BCAD FUND | 1,85,858 | 9.01 | 0.79% |
| LIC MF VALUE FUND | 1,03,110 | 5 | 0.44% |
| PGIM INDIA MULTI CAP FUND | 1,03,110 | 5 | 0.44% |
| SPARK MIDAS INVESTMENT FUND I | 1,03,110 | 5 | 0.44% |
| EDELWEISS LIFE INSURANCE CO.LTD. | 1,03,148 | 5 | 0.44% |
| AXIS MAX LIFE INSURANCE LTD.-UEGFH-HIGH GROWTH FUND II | 1,03,110 | 5 | 0.44% |
| CANARA HSBC LIFE INSURANCE CO.LTD. | 1,03,110 | 5 | 0.44% |
| INDUSIND NIPPON LIFE INSURANCE CO.LTD. | 1,03,110 | 5 | 0.44% |
| ABAKKUS SMALL CAP FUND | 1,03,110 | 5 | 0.44% |
| EASTSPRING INVESTMENTS INDIA INFRASTRUCTURE EQUITY OPEN LTD. | 1,03,110 | 5 | 0.44% |
| TAKSH INDIA ENTERPRISING FUND | 1,03,110 | 5 | 0.44% |
| CSIM INDIA OPPORTUNITIES FUND I | 1,03,110 | 5 | 0.44% |
| SOCIETE GENERALE-ODI | 1,03,110 | 5 | 0.44% |
| ALCHEMY EMERGING LEADERS OF TOMORROW-SERIES II | 1,03,110 | 5 | 0.44% |
Registrar, lead managers and documents
- Listing on
- BSE, NSE
- Face value
- ₹ 1 a share
- Registrar
- MUFG Intime India Private Limited
- Lead managers
- SBI Capital Markets Ltd., Axis Capital, ICICI Securities, Kotak Mahindra Capital Company Limited, Hdfc Bank Limited
- Red herring prospectus (RHP)
- Open
- Draft prospectus (DRHP)
- Open
- Basis of allotment
- Open
IPO dates, prices, grey market premium (GMP), subscription and the company overview: IPO Guru, updated three times a day. GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
Our recommendations are research opinions, not investment advice. Read the offer document (RHP) and consult your financial adviser before investing.